Probiotec Ltd
ASX:PBP

Watchlist Manager
Probiotec Ltd Logo
Probiotec Ltd
ASX:PBP
Watchlist
Price: 2.98 AUD Market Closed
Market Cap: 242.3m AUD

Gross Margin
Probiotec Ltd

30%
Current
30%
Average
48.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30%
=
Gross Profit
66.3m
/
Revenue
221.2m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
AU
Probiotec Ltd
ASX:PBP
242.3m AUD
30%
US
Eli Lilly and Co
NYSE:LLY
952.1B USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
494.4B USD
68%
CH
Roche Holding AG
SIX:ROG
253.5B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
212.4B GBP
82%
CH
Novartis AG
SIX:NOVN
205.7B CHF
76%
US
Merck & Co Inc
NYSE:MRK
245.7B USD
79%
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
82%
IE
Endo International PLC
LSE:0Y5F
202.5B USD
68%
US
Pfizer Inc
NYSE:PFE
146.6B USD
75%
No Stocks Found

Probiotec Ltd
Glance View

Market Cap
242.3m AUD
Industry
Pharmaceuticals

Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-11-14. The firm owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. The Company’s products are manufactured on behalf of a range of clients, including international companies. The company also owns Multipack-LJM business, a contract packer, providing packing services for a range of pharmaceutical, consumer healthcare, cosmetics and food, and beverage companies. The firm subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Biotech Pharmaceuticals Australia Pty Ltd, Biotech Pharmaceuticals Pty Ltd, Probiotec (NSW) Pty Ltd, Australian Dairy Proteins Pty Ltd, Milton Pharmaceuticals Pty Ltd and Willie Labs Generics Pty Ltd.

PBP Intrinsic Value
Not Available
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30%
=
Gross Profit
66.3m
/
Revenue
221.2m
What is the Gross Margin of Probiotec Ltd?

Based on Probiotec Ltd's most recent financial statements, the company has Gross Margin of 30%.

Back to Top